192 related articles for article (PubMed ID: 37179301)
1. Cirrhosis in intrahepatic cholangiocarcinoma: prognostic importance and impact on survival.
Thakral N; Gonzalez T; Nano O; Shin SH; Samuels S; Hussein A
BMC Gastroenterol; 2023 May; 23(1):151. PubMed ID: 37179301
[TBL] [Abstract][Full Text] [Related]
2. Effects of liver cirrhosis and patient condition on clinical outcomes in intrahepatic cholangiocarcinoma: a retrospective analysis of 156 cases in a single center.
Jesper D; Heyn SG; Schellhaas B; Pfeifer L; Goertz RS; Zopf S; Neurath MF; Strobel D
Eur J Gastroenterol Hepatol; 2018 May; 30(5):552-556. PubMed ID: 29280922
[TBL] [Abstract][Full Text] [Related]
3. Impact of cirrhosis on long-term survival outcomes of patients with intrahepatic cholangiocarcinoma.
Wang J; Qiu Y; Yang Y; Shen S; Zhi M; Zhang B; Wang W
Cancer Med; 2022 Oct; 11(19):3633-3642. PubMed ID: 35415945
[TBL] [Abstract][Full Text] [Related]
4. Dense GM-CSFR
Saranaruk P; Waraasawapati S; Chamgramol Y; Sawanyawisuth K; Paungpan N; Somphud N; Wongkham C; Okada S; Wongkham S; Vaeteewoottacharn K
PeerJ; 2023; 11():e14883. PubMed ID: 36883059
[TBL] [Abstract][Full Text] [Related]
5. Incremental value of volumetric multiparametric MRI over Fudan score for prognosis of unresectable intrahepatic cholangiocarcinoma treated with systemic chemotherapy.
Pandey A; Mohseni A; Shaghaghi M; Pandey P; Rezvani Habibabadi R; Hazhirkarzar B; Ly A; Panid Madani S; Borhani A; Kamel IR
Eur J Radiol; 2024 Jan; 170():111196. PubMed ID: 38029705
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma.
Zhang R; Li Q; Fu J; Jin Z; Su J; Zhang J; Chen C; Geng Z; Zhang D
BMC Cancer; 2021 Feb; 21(1):112. PubMed ID: 33535978
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA
J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748
[TBL] [Abstract][Full Text] [Related]
8. Impact of liver fibrosis score on prognosis after common therapies for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
Zhang JX; Li P; Chen Z; Lin H; Cai Z; Liao W; Pan Z
BMC Cancer; 2020 Jun; 20(1):556. PubMed ID: 32539768
[TBL] [Abstract][Full Text] [Related]
9. Analysis of metastasis and survival between extrahepatic and intrahepatic cholangiocarcinoma: A large population-based study.
Liao P; Cao L; Chen H; Pang SZ
Medicine (Baltimore); 2021 Apr; 100(16):e25635. PubMed ID: 33879742
[TBL] [Abstract][Full Text] [Related]
10. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
[TBL] [Abstract][Full Text] [Related]
11. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
[TBL] [Abstract][Full Text] [Related]
12. "Very early" intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients?
Sapisochin G; Rodríguez de Lope C; Gastaca M; Ortiz de Urbina J; Suarez MA; Santoyo J; Castroagudín JF; Varo E; López-Andujar R; Palacios F; Sanchez Antolín G; Perez B; Guiberteau A; Blanco G; González-Diéguez ML; Rodriguez M; Varona MA; Barrera MA; Fundora Y; Ferron JA; Ramos E; Fabregat J; Ciria R; Rufian S; Otero A; Vazquez MA; Pons JA; Parrilla P; Zozaya G; Herrero JI; Charco R; Bruix J
Am J Transplant; 2014 Mar; 14(3):660-7. PubMed ID: 24410861
[TBL] [Abstract][Full Text] [Related]
13. Comparing the clinicopathological characteristics of combined hepatocellular-cholangiocarcinoma with those of other primary liver cancers by use of the updated World Health Organization classification.
Yen CC; Yen CJ; Shan YS; Lin YJ; Liu IT; Huang HY; Yeh MM; Chan SH; Tsai HW
Histopathology; 2021 Oct; 79(4):556-572. PubMed ID: 33837585
[TBL] [Abstract][Full Text] [Related]
14. CS-iCCA, A New Clinically Based Staging System for Intrahepatic Cholangiocarcinoma: Establishment and External Validation.
Lozada ME; Zhang N; Jin W; Wongjarupong N; Yang JD; Voss MM; Prasai K; Amakye DO; Harmsen WS; Chaudhary S; Bathe OF; Borad MJ; Patel TC; Gores GJ; Therneau TM; Roberts LR
Am J Gastroenterol; 2023 Dec; 118(12):2173-2183. PubMed ID: 36940423
[TBL] [Abstract][Full Text] [Related]
15. Tumour stage and overall survival in patients with intrahepatic cholangiocarcinoma and primary sclerosing cholangitis - a retrospective cohort study.
Schramm C; Sapuk A; Hoyer D; Radünz S; Schmidt H
Z Gastroenterol; 2024 Jan; 62(1):37-42. PubMed ID: 38195106
[TBL] [Abstract][Full Text] [Related]
16. Tumor ratio of unsaturated to saturated sulfatide species is associated with disease-free survival in intrahepatic cholangiocarcinoma.
Huizing L; Chen L; Roeth AA; Heij LR; Flinders B; Bouwense SAW; Balluff B; Neumann UP; Heeren RMA; Olde Damink SWM; Vreeken RJ; Schaap FG
Cell Oncol (Dordr); 2023 Jun; 46(3):629-642. PubMed ID: 36630049
[TBL] [Abstract][Full Text] [Related]
17. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
[No Abstract] [Full Text] [Related]
18. [Cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma in cirrhotic patients].
Salinas M; Simian D; Carreño L; Cattaneo M; Urzúa Á; Sauré A; Lembach H; Castillo J; Díaz JC; Poniachik J
Rev Med Chil; 2022 Nov; 150(11):1431-1437. PubMed ID: 37358168
[TBL] [Abstract][Full Text] [Related]
19. Multiplexed gene expression profiling identifies the FGFR4 pathway as a novel biomarker in intrahepatic cholangiocarcinoma.
Yoo C; Kang J; Kim D; Kim KP; Ryoo BY; Hong SM; Hwang JJ; Jeong SY; Hwang S; Kim KH; Lee YJ; Hoeflich KP; Schmidt-Kittler O; Miller S; Choi EK
Oncotarget; 2017 Jun; 8(24):38592-38601. PubMed ID: 28445152
[TBL] [Abstract][Full Text] [Related]
20. Factors predicting surgical resection in patients with intrahepatic cholangiocarcinoma and cirrhosis.
Li H; Wu JS; Wang XT; Lv P; Gong LS; Liu G; Tian BN; Li YY; Jiang B
J Invest Surg; 2014 Aug; 27(4):219-25. PubMed ID: 24476002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
